Navigation Links
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Date:11/5/2009

ned in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be a
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Call for Applications: The Amgen Award for Science Teaching Excellence
2. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
3. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
6. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
7. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. Medarex to Receive Milestone Payment from Amgen
10. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
11. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Pharmasset, Inc. (Nasdaq... committed to discovering, developing and commerci...orted financial results for the fiscal year ended ...et held $58.4 million in cash, cash equivalents an...and 2009 Highlights ,, RG7128 ,, Phase ...
(Date:11/25/2009)...ov. 25 For many of the m...the 27 million living with untreated hearing loss...diologist Cindy Beyer. ,, Dr. Beyer, senior vic...ca,s largest hearing care and hearing aids compa...ess, frustration, and social isolation, "which can...
(Date:11/25/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, United States Dental Devices Market A...eportlinker.com/p0158733/United-States-Dental-Devi..., United States Dental Devices Market Analysis a...port is an essential source for in-depth informati...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Program Curbs Teen Substance Abuse Delinquency 56342 1Program Curbs Teen Substance Abuse Delinquency 56342 2Even Mild Infections Hasten Decline With Alzheimers 56340 1Even Mild Infections Hasten Decline With Alzheimers 56340 2Even Mild Infections Hasten Decline With Alzheimers 56340 3Researchers find first evidence of virus in malignant prostate cells 9818 1Researchers find first evidence of virus in malignant prostate cells 9818 2Researchers find first evidence of virus in malignant prostate cells 9818 3
(Date:11/29/2009)...get blamed for something leads to more self-defens...DAY, Nov. 29 (HealthDay News) -- The blame game is...the target is innocent. , Researchers found tha... problem, even if it,s an unfair accusation, they,...oo. , "When we see others protecting their ego...
(Date:11/28/2009)...GO, Nov. 28 Welcome to syngo&#...r the clinical routine from Siemens Healthcare. ...ons System (PACS) from Siemens where 2D, 3D, and... .plaza is poised to change the way multimodality ...nnovation at the 95th Scientific Assembly and An...
(Date:11/27/2009)...D, Mass., Nov. 27 GSI Gr...pplier of precision technology products and semico...eting of the Company,s shareholders has been sched...ation of the meeting will be announced in due cour... a requisition notice from Stephen Bershad, a hold...
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)...ing unprecedented medical, economic burdens, study... News) -- The number of people with diabetes in th...t 25 years, a new study predicts. , That would ...le with the disease, up from 23.7 million today. ,... with diabetes will triple, the study also warns, ...
Breaking Medicine News(10 mins):Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... very optimistic about Warfarin, an anti-clotting ...in patients suffering an abnormal heart rhythm, th...scores over the present treatment of Plavix plus a...,' Oral anticoagulants such as warfarin remain the...
...Pentagon placed new restrictions on a doctors’ ro... against any policy //that gives medical professi...ters’ to use harsher tactics than they would in t...ghts groups and medical ethicists. They charge tha...
...twins Amal and Amrutha, who became orphaned after ...ll be formally adopted by the Kerala Government at...being organised by Cheruvathur Grama Panchayat to ...a recent Cabinet meeting mooted the idea of adopti...
... popular excuse "not tonight, I have a headache," ...oid sexual activity and says that sexual desire an...mical. // In fact, migraine sufferers report...d colleagues. 'Migraine patients in general m...
...as long been associated with mesothelioma and lung...gnancies as well //. The Indian Institute of...addition IOM also concluded that there was ‘sugges...fficient evidence to relate asbestos to esophageal...
...nd Healthcare products Regulatory Agency (MHRA) wa...ulty readings. The diabetic patients are cautioned...e found to giving readings which were far too high...s of insulin resulting in hypoglycaemic coma. ...
Other Medicine News:Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:Laryngeal Cancer Added to Asbestos’ Crime Lis 2
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: